Kyntra Bio (KYNB) Leases (2019 - 2024)
Historic Leases for Kyntra Bio (KYNB) over the last 6 years, with Q4 2024 value amounting to $97000.0.
- Kyntra Bio's Leases fell 9985.06% to $97000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $97000.0, marking a year-over-year decrease of 9985.06%. This contributed to the annual value of $97000.0 for FY2024, which is 9985.06% down from last year.
- Per Kyntra Bio's latest filing, its Leases stood at $97000.0 for Q4 2024, which was down 9985.06% from $56.1 million recorded in Q3 2024.
- In the past 5 years, Kyntra Bio's Leases registered a high of $97.1 million during Q2 2021, and its lowest value of $97000.0 during Q4 2024.
- Over the past 5 years, Kyntra Bio's median Leases value was $74.4 million (recorded in 2023), while the average stood at $66.4 million.
- As far as peak fluctuations go, Kyntra Bio's Leases soared by 248794.12% in 2022, and later crashed by 9985.06% in 2024.
- Over the past 5 years, Kyntra Bio's Leases (Quarter) stood at $37.0 million in 2020, then soared by 151.84% to $93.2 million in 2021, then decreased by 14.3% to $79.9 million in 2022, then decreased by 18.72% to $64.9 million in 2023, then crashed by 99.85% to $97000.0 in 2024.
- Its Leases was $97000.0 in Q4 2024, compared to $56.1 million in Q3 2024 and $61.2 million in Q2 2024.